The Effect of Xevinapant Combined with Ionizing Radiation on HNSCC and Normal Tissue Cells and the Impact of Xevinapant on Its Targeted Proteins cIAP1 and XIAP
The poor prognosis of HNSCC is partly due to treatment resistance. The SMAC mimetic Xevinapant is a promising new approach to targeted cancer therapy. Xevinapant inhibits cIAP1/2 and XIAP, leading to apoptosis, necroptosis and inhibition of prosurvival signaling. Combining Xevinapant with IR could i...
Main Authors: | Julia Fleischmann, Laura S. Hildebrand, Lukas Kuhlmann, Rainer Fietkau, Luitpold V. Distel |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-06-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/12/12/1653 |
Similar Items
-
TRIM56 promotes malignant progression of glioblastoma by stabilizing cIAP1 protein
by: Xu Yang, et al.
Published: (2022-12-01) -
cIAP-2 Expression Increases in Elderly Patients with Squamous Cell Carcinoma of the Head and Neck
by: Chi-Long Chen, et al.
Published: (2017-03-01) -
Cellular inhibitor of apoptosis 2 (cIAP2) restricts neuroinflammation during experimental autoimmune encephalomyelitis
by: Debolina D. Biswas, et al.
Published: (2022-06-01) -
TWEAK Promotes the Proliferation of Squamous Cell Carcinoma Cells Through Activating cIAP1 Signals
by: Lili Liang, et al.
Published: (2020-04-01) -
Hepatitis B virus induces sorafenib resistance in liver cancer via upregulation of cIAP2 expression
by: Shouhua Zhang, et al.
Published: (2021-03-01)